Αποτελέσματα Αναζήτησης
The MHRA products website allows you to find: The leaflets which are provided with medicines. The description of the medicinal product’s properties and how it can be used. Scientific reports...
- About This Service
About this service SPC-PILs. Patient information leaflet...
- Yellow Card
Our ninth annual #MedSafetyWeek campaign runs from 4 to 10...
- About This Service
30 Αυγ 2024 · From 1 January 2025, the MHRA will regulate medicines through UK-wide marketing authorisations (MAs). Any authorisation issued on or after this date, will have an MA number with a PL prefix.
19 Δεκ 2019 · Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
31 Δεκ 2020 · Guidance. Converting Centrally Authorised Products (CAPs) to UK Marketing Authorisations (MAs), 'grandfathering' and managing lifecycle changes. This guidance covers ‘grandfathering’ and managing...
How to use the BP. Download PDF version. The BP is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It contains all texts and monographs of the European Pharmacopoeia (signposted with a chaplet of stars), as well as the national standards developed by the BP.
The MHRA guidance refers to the automatic conversion of CAPs into MAs effective in Great Britain (GB) only and issued with a GB MA number on 1 January 2021. This is referred to as ‘Grandfathering’ and these UK MAs are referred to as ‘converted EU MAs’.
Healthcare products Regulatory Agency (MHRA) regulates medicinal products for human use in accordance with the European Community’s medicinal products directive (Directive 2001/83/EC, as...